In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA

被引:5
|
作者
Findlay, Jacqueline [1 ]
Bianco, Gabriele [2 ,3 ]
Boattini, Matteo [2 ,3 ]
Nordmann, Patrice [1 ,4 ]
机构
[1] Univ Fribourg, Fac Sci & Med, Med & Mol Microbiol, Fribourg, Switzerland
[2] Univ Hosp Citta Salute & Sci Torino, Microbiol & Virol Unit, Turin, Italy
[3] Univ Torino, Dept Publ Hlth & Paediat, Turin, Italy
[4] Univ Fribourg, Swiss Natl Reference Ctr Emerging Antibiot Resist, Fribourg, Switzerland
关键词
D O I
10.1093/jac/dkae018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:928 / 930
页数:3
相关论文
共 50 条
  • [1] Cefiderocol in Combating Carbapenem-Resistant Acinetobacter baumannii: Action and Resistance
    Yousefi, Bahman
    Kashanipoor, Setayesh
    Mazaheri, Payman
    Alibabaei, Farnaz
    Babaeizad, Ali
    Asli, Shima
    Mohammadi, Sina
    Gorgin, Amir Hosein
    Alipour, Tahereh
    Oksenych, Valentyn
    Eslami, Majid
    BIOMEDICINES, 2024, 12 (11)
  • [2] Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence ISAba36 in the siderophore receptor pirA
    Huang, En
    Thompson, Rebekah N.
    Moon, Sun Hee
    Keck, Jacob M.
    Lowry, Michael S.
    Melero, Joe
    Jun, Se-Ran
    Rosenbaum, Eric R.
    Dare, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (07) : e0029024
  • [3] The role of TonB-dependent copper receptor in virulence of Acinetobacter baumannii
    Abdollahi, Sajad
    Rasooli, Iraj
    Gargari, Seyed Latif Mousavi
    INFECTION GENETICS AND EVOLUTION, 2018, 60 : 181 - 190
  • [4] Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues
    Desmoulin, Anissa
    Sababadichetty, Loik
    Kamus, Laure
    Daniel, Marion
    Feletti, Lucie
    Allou, Nicolas
    Potron, Anals
    Leroy, Anne-Gaelle
    Jaffar-Bandjee, Marie -Christine
    Belmonte, Olivier
    Garrigos, Thomas
    Miltgen, Guillaume
    HELIYON, 2024, 10 (09)
  • [5] Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii
    Karruli, Arta
    Migliaccio, Antonella
    Pournaras, Spyros
    Durante-Mangoni, Emanuele
    Zarrilli, Raffaele
    ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [6] Resistance to Cefiderocol Involved Expression of PER-1?-Lactamase and Downregulation of Iron Transporter System in Carbapenem-Resistant Acinetobacter baumannii
    He, Yukun
    Wang, Yifan
    Ma, Xinqian
    Zhao, Lili
    Guan, Jie
    Zhao, Jin
    Yu, Wenyi
    Li, Yanjun
    Ni, Wentao
    Gao, Zhancheng
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7177 - 7187
  • [7] Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections
    Shields, Ryan K.
    Dorazio, Ava J.
    Tiseo, Giusy
    Squires, Kevin M.
    Leonildi, Alessandro
    Giordano, Cesira
    Kline, Ellen G.
    Barnini, Simona
    Iovleva, Alina
    Griffith, Marissa P.
    Van Tyne, Daria
    Doi, Yohei
    Falcone, Marco
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
  • [8] Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection
    Mabayoje, Diana A.
    NicFhogartaigh, Caoimhe
    Cherian, Benny P.
    Tan, Mei Gie Meiqi
    Wareham, David W.
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 : 21 - 24
  • [9] Pharmacokinetics of cefiderocol in a patient with carbapenem-resistant Acinetobacter baumannii ventriculitis: A case report
    Finch, Natalie A.
    Granillo, Alejandro
    Pouya, Nazanin
    Bhimraj, Adarsh
    Miller, William R.
    Tam, Vincent H.
    PHARMACOTHERAPY, 2025, 45 (01): : 66 - 69
  • [10] Activity of cefiderocol in combination with tetracycline analogues against carbapenem-resistant Acinetobacter baumannii
    Yin, Yuhan
    Xu, Na
    Wang, Xinjie
    JOURNAL OF ANTIBIOTICS, 2025, 78 (03): : 190 - 196